Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation

This study has been completed.
Information provided by:
Dompé Farmaceutici S.p.A Identifier:
First received: November 2, 2005
Last updated: June 7, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)